Pharmacotherapy for obsessive-compulsive disorder
✍ Scribed by Darin D. Dougherty; Scott L. Rauch; Michael A. Jenike
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 69 KB
- Volume
- 60
- Category
- Article
- ISSN
- 0021-9762
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Pharmacotherapeutic options for obsessive‐compulsive disorder (OCD) have expanded over the past half‐century since medications were first found to be effective for the treatment of OCD. Currently, the serotonin reuptake inhibitors (SRIs) represent the first‐line pharmacotherapy for OCD. High dosages and long trials of the SRIs are needed for adequate treatment of OCD. The use of SRIs for the treatment of OCD is reviewed, then other pharmacotherapeutic treatment options, including SRI augmentation and alternative monotherapies, are discussed. The preponderance of data demonstrates that SRI augmentation with neuroleptics is efficacious for treatment‐refractory OCD. There is substantially less evidence supporting other alternative strategies. Finally, neurosurgical and device‐based approaches for treatment‐refractory OCD are reviewed. © 2004 Wiley Periodicals, Inc. J Clin Psychol/In Session.
📜 SIMILAR VOLUMES
There has been considerable debate with respect to the relationship between Obsessive Compulsive Disorder (OCD) and psychotic phenomena. In the present study, a large sample of subjects suffering from OCD completed a self report instrument of features associated with Schizotypal Personality Disorder
Obsessive-compulsive disorder (OCD) is a well-recognized psychiatric disorder often beginning in reproductive age. A case of OCD in pregnancy is presented and its management discussed. A 28-year-old G3P2 woman presented at 8 weeks' gestation for prenatal care. She had been diagnosed with OCD followi
Several lines of evidence support the concept of obsessive-compulsive disorder (OCD) as a heterogeneous illness. Using a range of factors such as demographic, psychosocial, and clinical variables, we compared OCD patients with chronic (n = 55) versus episodic (n = 46) courses of illness. Patients we